comprehensive -WSS

comprehensive

author：fashion 2025-09-27 22:47:16 - browse：4

Golden brain and DNA spiral illustration. -- biotech coverage from STAT — Adobe

The dream of being able to pluck a cell therapy off of a freezer shelf and speedily give it to cancer patients is materializing in the cancer world. Now, a new biotech hopes to do the same for patients with neurological conditions.

Kenai Therapeutics closed a $82 million Series A round Thursday co-led by Cure Ventures, The Column Group, and sovereign wealth fund Alaska Permanent Fund Corp. The San Diego-based biotech has big plans for that money — it’s already identified its lead drug candidate for people with Parkinson’s disease, and plans to move into a clinical trial within the next year.

Kenai — pronounced key-nigh — is developing therapies that use induced pluripotent stem cells, or iPSCs. These highly versatile organisms are derived from skin or blood cells and can be transformed into any type of cell. In Parkinson’s, the idea is that these cells would replace damaged neurons.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Why do we get seasonal allergies?

knowledge

WSS

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Illumina to lay off 10% of research and development team

My superpower is killing ticks

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

focus

comprehensive

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Dobbs anniversary: the lost opportunity of abortion as health care

What the cancer research community can learn from the Covid response

Medical records are filled with copy

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Walensky prepares to leave CDC — and Congress — behind

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

focus

Verily hires former Apple Health leader as chief scientific officer

'Ancient DNA,' 23andMe reveal African American ancestries

Illumina to lay off 10% of research and development team

What Mike Pence has said that could be used in a Donald Trump trial

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

UnitedHealth wins $3.3 billion takeover of Amedisys

focus

focus

knowledge

hotspot